|
1
|
Cohen J: The immunopathogenesis of sepsis.
Nature. 420:885–891. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bonventre JV and Yang L: Cellular
pathophysiology of ischemic acute kidney injury. J Clin Invest.
121:4210–4221. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duzova A, Bakkaloglu A, Kalyoncu M,
Poyrazoglu H, Delibas A, Ozkaya O, Peru H, Alpay H, Soylemezoglu O,
Gur-Guven A, et al: Etiology and outcome of acute kidney injury in
children. Pediatr Nephrol. 25:1453–1461. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fiser RT, West NK, Bush AJ, Sillos EM,
Schmidt JE and Tamburro RF: Outcome of severe sepsis in pediatric
oncology patients. Pediatr Crit Care Med. 6:531–536. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chawla LS and Kimmel PL: Acute kidney
injury and chronic kidney disease: An integrated clinical syndrome.
Kidney Int. 82:516–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brophy PD: Renal supportive therapy for
pediatric acute kidney injury in the setting of multiorgan
dysfunction syndrome/sepsis. Semin Nephrol. 28:457–469. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Solhaug MJ, Ballèvre LD, Guignard JP,
Granger JP and Adelman RD: Nitric oxide in the developing kidney.
Pediatr Nephrol. 10:529–539. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seely KA, Holthoff JH, Burns ST, Wang Z,
Thakali KM, Gokden N, Rhee SW and Mayeux PR: Hemodynamic changes in
the kidney in a pediatric rat model of sepsis-induced acute kidney
injury. Am J Physiol Renal Physiol. 301:F209–F217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitada M and Koya D: Renal protective
effects of resveratrol. Oxid Med Cell Longev. 2013:5680932013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bertelli AA and Das DK: Grapes, wines,
resveratrol, and heart health. J Cardiovasc Pharmacol. 54:468–476.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sharma S, Anjaneyulu M, Kulkarni SK and
Chopra K: Resveratrol, a polyphenolic phytoalexin, attenuates
diabetic nephropathy in rats. Pharmacology. 76:69–75. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Palsamy P and Subramanian S: Resveratrol
protects diabetic kidney by attenuating hyperglycemia-mediated
oxidative stress and renal inflammatory cytokines via Nrf2-Keap1
signaling. Biochim Biophys Acta. 1812:719–731. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim MY, Lim JH, Youn HH, Hong YA, Yang KS,
Park HS, Chung S, Ko SH, Shin SJ, Choi BS, et al: Resveratrol
prevents renal lipotoxicity and inhibits mesangial cell
glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in
db/db mice. Diabetologia. 56:204–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Pang S, Deng B, Qian L, Chen J,
Zou J, Zheng J, Yang L, Zhang C, Chen X, et al: High glucose
induces renal mesangial cell proliferation and fibronectin
expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is
inhibited by resveratrol. Int J Biochem Cell Biol. 44:629–638.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stojanović S, Sprinz H and Brede O:
Efficiency and mechanism of the antioxidant action of
trans-resveratrol and its analogues in the radical liposome
oxidation. Arch Biochem Biophys. 391:79–89. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu
S and Kong AN: Activation of Nrf2-antioxidant signaling attenuates
NFkappaB-inflammatory response and elicits apoptosis. Biochem
Pharmacol. 76:1485–1489. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu M, Grigoryev DN, Crow MT, Haas M,
Yamamoto M, Reddy SP and Rabb H: Transcription factor Nrf2 is
protective during ischemic and nephrotoxic acute kidney injury in
mice. Kidney Int. 76:277–285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soeur J, Eilstein J, Léreaux G, Jones C
and Marrot L: Skin resistance to oxidative stress induced by
resveratrol: from Nrf2 activation to GSH biosynthesis. Free Radic
Biol Med. 78:213–223. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rubiolo JA and Vega FV: Resveratrol
protects primary rat hepatocytes against necrosis induced by
reactive oxygen species. Biomed Pharmacother. 62:606–612. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ungvari Z, Bagi Z, Feher A, Recchia FA,
Sonntag WE, Pearson K, de Cabo R and Csiszar A: Resveratrol confers
endothelial protection via activation of the antioxidant
transcription factor Nrf2. Am J Physiol Heart Circ Physiol.
299:H18–H24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Holthoff JH, Wang Z, Seely KA, Gokden N
and Mayeux PR: Resveratrol improves renal microcirculation,
protects the tubular epithelium, and prolongs survival in a mouse
model of sepsis-induced acute kidney injury. Kidney Int.
81:370–378. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen L, Yang S, Zumbrun EE, Guan H,
Nagarkatti PS and Nagarkatti M: Resveratrol attenuates
lipopolysaccharide-induced acute kidney injury by suppressing
inflammation driven by macrophages. Mol Nutr Food Res. 59:853–864.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miyaji T, Hu X, Yuen PS, Muramatsu Y, Iyer
S, Hewitt SM and Star RA: Ethyl pyruvate decreases sepsis-induced
acute renal failure and multiple organ damage in aged mice. Kidney
Int. 64:1620–1631. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ichimura T, Bonventre JV, Bailly V, Wei H,
Hession CA, Cate RL and Sanicola M: Kidney injury molecule-1
(KIM-1), a putative epithelial cell adhesion molecule containing a
novel immunoglobulin domain, is up-regulated in renal cell after
injury. J Biol Chem. 273:4135–4142. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pedruzzi LM, Stockler-Pinto MB, Leite M Jr
and Mafra D: Nrf2-keap1 system versus NF-κB: The good and the evil
in chronic kidney disease? Biochimie. 94:2461–2466. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thimmulappa RK, Lee H, Rangasamy T, Reddy
SP, Yamamoto M, Kensler TW and Biswal S: Nrf2 is a critical
regulator of the innate immune response and survival during
experimental sepsis. J Clin Invest. 116:984–995. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Soeur J, Eilstein J, Léreaux G, Jones C
and Marrot L: Skin resistance to oxidative stress induced by
resveratrol: From Nrf2 activation to GSH biosynthesis. Free Radical
Biol Med. 78:213–223. 2015. View Article : Google Scholar
|
|
29
|
Weiss M, Huber-Lang M, Taenzer M, Kron M,
Hay B and Schneider M: Which cut-off should be used in the SOFA
score for one organ system to define organ dysfunction, and, thus,
severe SIRS/sepsis underlying the 1992 ACCP/SCCM sepsis definitions
in critically ill surgical patients? Infection. 37:41. 2009.
|
|
30
|
Gupta A, Gupta A, Nigam D, Shukla GS and
Agarwal AK: Profile of reactive oxygen species generation and
antioxidative mechanisms in the maturing rat kidney. J Appl
Toxicol. 19:55–59. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tóth-Heyn P, Drukker A and Guignard JP:
The stressed neonatal kidney: From pathophysiology to clinical
management of neonatal vasomotor nephropathy. Pediatr Nephrol.
14:227–239. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng C, Sun ZC, Tong G, Yi W, Ma L, Zhao
B, Cheng L, Zhang J, Cao F and Yi D: α-lipoic acid reduces infarct
size and preserves cardiac function in rat myocardial
ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2
pathway. PLoS One. 8:e583712013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zheng H, Whitman SA, Wu W, Wondrak GT,
Wong PK, Fang D and Zhang DD: Therapeutic potential of Nrf2
activators in streptozotocin-induced diabetic nephropathy.
Diabetes. 60:3055–3066. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pedruzzi LM, Stockler-Pinto MB, Leite M Jr
and Matra D: Nrf2-keap1 system versus NF-κB: The good and the evil
in chronic kidney disease? Biochimie. 94:2461–2466. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Csaki C, Mobasheri A and Shakibaei M:
Synergistic chondroprotective effects of curcumin and resveratrol
in human articular chondrocytes: Inhibition of IL-1beta-induced
NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther.
11:R1652009. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kitada M, Kume S, Takeda-Watanabe A,
Kanasaki K and Koya D: Sirtuins and renal diseases: Relationship
with aging and diabetic nephropathy. Clin Sci (Lond). 124:153–164.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang YT, Chen YY, Lai YH, Cheng CC, Lin
TC, Su YS, Liu CH and Lai PC: Resveratrol alleviates the
cytotoxicity induced by the radiocontrast agent, ioxitalamate, by
reducing the production of reactive oxygen species in HK-2 human
renal proximal tubule epithelial cells in vitro. Int J Mol Med.
37:83–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng AS, Cheng YH, Chiou CH and Chang TL:
Resveratrol upregulates Nrf2 expression to attenuate
methylglyoxal-induced insulin resistance in Hep G2 cells. J Agric
Food Chem. 60:9180–9187. 2012. View Article : Google Scholar : PubMed/NCBI
|
